Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)

Universe Pharmaceuticals has disclosed Receivables - Net across 6 years of filings, most recently posting $13.0 billion for Q3 2025.

• Receivables - Net for Q3 2025 came in at $13.0 billion, up 0.79% year-over-year; the trailing twelve-month figure through Sep 2025 was $13.0 billion (up 0.79% YoY), and the FY2025 annual result was $13.0 billion, up 0.79% from the prior year.
• Receivables - Net came in at $13.0 billion for Q3 2025 at Universe Pharmaceuticals, up from $12.9 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $13.0 billion in Q3 2025 to a low of $11.0 million in Q3 2023.
• The 5-year median for Receivables - Net is $16.8 million (2021), against an average of $3.3 billion.
• Across the five-year window, Receivables - Net tumbled 100.0% in 2021 and jumped 117066.85% in 2024, its largest moves.
• Universe Pharmaceuticals' Receivables - Net stood at $16.0 million in 2021, then fell by 5.22% to $15.2 million in 2022, then slipped by 27.46% to $11.0 million in 2023, then surged by 117066.85% to $12.9 billion in 2024, then grew by 0.79% to $13.0 billion in 2025.
• The last three Receivables - Net figures came in at $13.0 billion (Q3 2025), $12.9 billion (Q3 2024), and $14.4 million (Q1 2024), per Business Quant data.